These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 9747280

  • 21. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
    Hofbauer GF, Marcollo-Pini A, Corsenca A, Kistler AD, French LE, Wüthrich RP, Serra AL.
    Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.
    Wheless JW, Almoazen H.
    J Child Neurol; 2013 Jul; 28(7):933-6. PubMed ID: 23680945
    [Abstract] [Full Text] [Related]

  • 24. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis.
    Weiss ET, Geronemus RG.
    Lasers Surg Med; 2010 Jul; 42(5):357-60. PubMed ID: 20583249
    [Abstract] [Full Text] [Related]

  • 25. [Eyelid and cutaneous lesions as the sole indicators of tuberous sclerosis].
    Mencía-Gutiérrez E, Gutiérrez-Díaz E, Ricoy JR, Sánez-Madrazo N.
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):401-4. PubMed ID: 15306968
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genital angiofibromas in tuberous sclerosis: two cases.
    Nico MM, Ito LM, Valente NY.
    J Dermatol; 1999 Feb; 26(2):111-4. PubMed ID: 10091481
    [Abstract] [Full Text] [Related]

  • 28. Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis.
    Kacerovska D, Kerl K, Michal M, Filipova H, Vrtel R, Vanecek T, Zelenakova H, Kraus J, Kodet R, Kazakov DV.
    J Am Acad Dermatol; 2012 Dec; 67(6):1319-26. PubMed ID: 22552000
    [Abstract] [Full Text] [Related]

  • 29. Topical everolimus for facial angiofibromas in the tuberous sclerosis complex. A first case report.
    Dill PE, De Bernardis G, Weber P, Lösch U.
    Pediatr Neurol; 2014 Jul; 51(1):109-13. PubMed ID: 24810875
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Autopsy findings in a case of tuberous sclerosis.
    Noone P, Majid M, Vasu S.
    J Forensic Leg Med; 2009 Aug; 16(6):357-61. PubMed ID: 19573851
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tuberous sclerosis: a novel approach to diagnosis.
    Jahagirdar PB, Eeraveni R, Ponnuraj S, Kamarthi N.
    J Indian Soc Pedod Prev Dent; 2011 Dec; 29(6 Suppl 2):S52-5. PubMed ID: 22169838
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.